Pharmacist’s Role in Modern Menopause Care Beyond Black Box Warnings

For decades, the pharmacy counter has been a site of hesitation for women seeking relief from menopausal symptoms, often due to the stark safety warnings that once dominated the packaging of hormone replacement therapy (HRT). This landscape changed fundamentally when the FDA officially approved significant labeling updates for 6 menopausal hormone therapy products, removing risk statements regarding cardiovascular disease, breast cancer, and probable dementia from the black box warning.^1,2